Lancet: HRT 'increases ovarian cancer risk'

Women who undergo hormone replacement therapy are at increased risk of getting ovarian cancer, according to a study published in the Lancet medical journal.

Analysis by the University of Oxford found there was one extra case for every 1,000 women receiving the treatment for five years from the age of 50.

Fergus Walsh reports.

  • Subsection
  • Published